69 related articles for article (PubMed ID: 8742419)
21. Effect of NG-nitro-L-arginine on age-related changes of glutamate receptor systems and immunophilin in rats.
Araki T; Oshima Y; Kato H; Shuto K; Itoyama Y
Methods Find Exp Clin Pharmacol; 1997; 19(6):373-81. PubMed ID: 9385586
[TBL] [Abstract][Full Text] [Related]
22. Selective block of N-methyl-D-aspartic acid (NMDA)-evoked whole-cell currents in mouse cultured spinal neurones by CGP 40116.
D'Hooge R; Raes A; Van Bogaert PP; Geelhand M; De Deyn PP
Br J Pharmacol; 1997 Jan; 120(2):211-4. PubMed ID: 9117111
[TBL] [Abstract][Full Text] [Related]
23. Characterization of haloperidol and trifluperidol as subtype-selective N-methyl-D-aspartate (NMDA) receptor antagonists using [3H]TCP and [3H]ifenprodil binding in rat brain membranes.
Coughenour LL; Cordon JJ
J Pharmacol Exp Ther; 1997 Feb; 280(2):584-92. PubMed ID: 9023267
[TBL] [Abstract][Full Text] [Related]
24. Use of subunit-specific antisense oligodeoxynucleotides to define developmental changes in the properties of N-methyl-D-aspartate receptors.
Zhong J; Gribkoff VK; Molinoff PB
Mol Pharmacol; 1996 Sep; 50(3):631-8. PubMed ID: 8794904
[TBL] [Abstract][Full Text] [Related]
25. CGP 39653 binding in the chick CNS after NMDA receptor antagonist treatment.
White BH; Vogel MW
J Neural Transm (Vienna); 1996; 103(11):1247-53. PubMed ID: 9013411
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological characterization of Ro 63-1908 (1-[2-(4-hydroxy-phenoxy)-ethyl]-4-(4-methyl-benzyl)-piperidin-4-ol), a novel subtype-selective N-methyl-D-aspartate antagonist.
Gill R; Alanine A; Bourson A; Buttelmann B; Fischer G; Heitz MP; Kew JN; Levet-Trafit B; Lorez HP; Malherbe P; Miss MT; Mutel V; Pinard E; Roever S; Schmitt M; Trube G; Wybrecht R; Wyler R; Kemp JA
J Pharmacol Exp Ther; 2002 Sep; 302(3):940-8. PubMed ID: 12183650
[TBL] [Abstract][Full Text] [Related]
27. Functional in vitro characterization of CR 3394: a novel voltage dependent N-methyl-D-aspartate (NMDA) receptor antagonist.
Losi G; Lanza M; Makovec F; Artusi R; Caselli G; Puia G
Neuropharmacology; 2006 Mar; 50(3):277-85. PubMed ID: 16236334
[TBL] [Abstract][Full Text] [Related]
28. Cloning of a brain N-methyl-D-aspartate- and D, L-epsilon-2-amino-4-propyl-5-phosphono-3-pentanoic acid (CGP 39653)-binding protein.
Kumar KN; Johnson PS; Chen X; Pal R; Ahmad M; Ragland T; Bigge C; Michaelis EK
Biochem Biophys Res Commun; 1998 Dec; 253(2):463-9. PubMed ID: 9878559
[TBL] [Abstract][Full Text] [Related]
29. Inorganic iron complexes derived from the nitric oxide donor nitroprusside: competitive N-methyl-D-aspartate receptor antagonists with nanomolar affinity.
Neijt H; Koller M; Urwyler S
Biochem Pharmacol; 2001 Feb; 61(3):343-9. PubMed ID: 11172739
[TBL] [Abstract][Full Text] [Related]
30. Cocaine-induced kindling is associated with elevated NMDA receptor binding in discrete mouse brain regions.
Itzhak Y; Martin JL
Neuropharmacology; 2000; 39(1):32-9. PubMed ID: 10665817
[TBL] [Abstract][Full Text] [Related]
31. Extracts from rhizomes of Cyperus articulatus (Cyperaceae) displace [3H]CGP39653 and [3H]glycine binding from cortical membranes and selectively inhibit NMDA receptor-mediated neurotransmission.
Bum EN; Meier CL; Urwyler S; Wang Y; Herrling PL
J Ethnopharmacol; 1996 Nov; 54(2-3):103-11. PubMed ID: 8953423
[TBL] [Abstract][Full Text] [Related]
32. Stress persistently increases NMDA receptor-mediated binding of [3H]PDBu (a marker for protein kinase C) in the amygdala, and re-exposure to the stressful context reactivates the increase.
Shors TJ; Elkabes S; Selcher JC; Black IB
Brain Res; 1997 Mar; 750(1-2):293-300. PubMed ID: 9098555
[TBL] [Abstract][Full Text] [Related]
33. Autoradiography of [3H]alpha,beta-methylene-ATP binding sites in medulla oblongata and spinal cord of the rat.
Tuyau M; Hansen MA; Coleman MJ; Dampney RA; Balcar VJ; Bennett MR
Neurochem Int; 1997 Feb; 30(2):159-69. PubMed ID: 9017663
[TBL] [Abstract][Full Text] [Related]
34. Adaptation of cortical NMDA receptors by chronic treatment with specific serotonin reuptake inhibitors.
Nowak G; Legutko B; Skolnick P; Popik P
Eur J Pharmacol; 1998 Jan; 342(2-3):367-70. PubMed ID: 9548410
[TBL] [Abstract][Full Text] [Related]
35. N-methyl-D-aspartate receptors are transiently expressed in the developing spinal cord ventral horn.
Kalb RG; Lidow MS; Halsted MJ; Hockfield S
Proc Natl Acad Sci U S A; 1992 Sep; 89(18):8502-6. PubMed ID: 1356265
[TBL] [Abstract][Full Text] [Related]
36. N-methyl-D-aspartate receptor binding in brains of rats at different ages.
Shimada A; Mukhin A; Ingram DK; London ED
Neurobiol Aging; 1997; 18(3):329-33. PubMed ID: 9263199
[TBL] [Abstract][Full Text] [Related]
37. A novel fluorescent GSH-adduct binds to the NMDA receptor.
Shaw CA; Pasqualotto BA; Curry K; Kim SU; LeCompte KA; Langmuir ME
J Neurosci Methods; 1999 Oct; 93(1):21-6. PubMed ID: 10598861
[TBL] [Abstract][Full Text] [Related]
38. Adaptation of the NMDA receptor in rat cortex following chronic electroconvulsive shock or imipramine.
Paul IA; Layer RT; Skolnick P; Nowak G
Eur J Pharmacol; 1993 Nov; 247(3):305-11. PubMed ID: 7905831
[TBL] [Abstract][Full Text] [Related]
39. Effects of NMDA-R1 antisense oligodeoxynucleotide administration: behavioral and radioligand binding studies.
Zapata A; Capdevila JL; Tarrason G; Adan J; MartÃnez JM; Piulats J; Trullas R
Brain Res; 1997 Jan; 745(1-2):114-20. PubMed ID: 9037399
[TBL] [Abstract][Full Text] [Related]
40. Dynorphin potentiation of [3H]CGP-39653 binding to rat brain membranes.
Dumont M; Lemaire S
Eur J Pharmacol; 1994 Dec; 271(1):241-4. PubMed ID: 7698209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
